Skip to main content
The Journal of Clinical Hypertension logoLink to The Journal of Clinical Hypertension
letter
. 2021 Mar 30;23(5):1093. doi: 10.1111/jch.14247

Blood pressure lowering in pregnancy

Piotr Sobieraj 1,
PMCID: PMC8678756  PMID: 33784437

Liu et al 1 demonstrated the effect of various states of hypertension and other factors on low birth weight (LBW) and small for gestational age (SGA) in pregnancy. In the large prospective study, the authors showed how strongly the diagnosis of hypertension in pregnancy and pre‐eclampsia affects the risk of LBW and SGA. The authors conclude that their results may be a premise for preventive measures to identify risk factors for an unfavorable pregnancy outcome related to hypertension.

However, according to the current state of knowledge, the possibilities of preventing the negative effects of high blood pressure in pregnancy are limited. In the randomized Control of Hypertension in Pregnancy Study (CHIPS), which aimed to compare the reduction in diastolic blood pressure to tight control <85 mmHg and less‐tight control <100 mmHg, no difference according to SGA (defined as birth weight <10th percentile or <3rd percentile) was found. 2 There were also no differences in terms of risk of pregnancy loss, high‐level neonatal care, and maternal complications. Merely, it was shown that tight control was associated with the lower incidence of severe maternal hypertension in comparison with less‐tight control.

Regarding Liu's results, it is interesting how blood pressure lowering would affect LBW/SGA risk. Likewise, since the target blood pressure in pregnancy is unknown, it is extremely important to understand the relationship between achieved blood pressure and pregnancy outcomes. Unfortunately, no blood pressure values were reported.

According to the position paper on the peripartum management of hypertension by the European Society of Cardiology Council on Hypertension and the European Society of Hypertension, these issues should be addressed to researchers in the field of hypertension in pregnancy as they represent significant gaps in knowledge. 3

CONFLICT OF INTEREST

The author declares that there is no conflict of interest.

AUTHOR CONTRIBUTIONS

Piotr Sobieraj contributed to the conception of the manuscript, drafting the review paper, and final approval of the version to be published.

Sobieraj P. Blood pressure lowering in pregnancy. J Clin Hypertens. 2021;23:1093–1093. 10.1111/jch.14247

REFERENCES

  • 1. Liu Y, Li N, Li Z, et al. Impact of gestational hypertension and pre‐eclampsia on low birthweight and small‐for‐gestational‐age infants in China: A large prospective cohort study. J Clin Hypertens. 2021:1‐8. 10.1111/jch.1417 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Magee LA, von Dadelszen P, Rey E, et al. Less‐tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372(5):407‐417. 10.1056/NEJMoa1404595 [DOI] [PubMed] [Google Scholar]
  • 3. Cífková R, Johnson MR, Kahan T, et al. Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension. Eur Hear J ‐ Cardiovasc Pharmacother. 2020;6(6):384‐393. 10.1093/ehjcvp/pvz082 [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Clinical Hypertension are provided here courtesy of Wiley

RESOURCES